Xicheng David Sun

This inventor holds 49 USPTO granted patents and 8 published patent applications, plus 4 CIPO patents and 16 EPO patents, primarily in S-Nitrosoglutathione Reductase Inhibitors. Top assignees: Nivalis Therapeutics, Inc., N30 Pharmaceuticals, Inc., Crestone, Inc.. Active years: 2003-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xicheng David Sun. Retrieved from https://idiyas.com/inventor/xicheng-david-sun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 49 (Patent Applications = 8)

% Patents Active = 18.4

CIPO Patents = 4

EPO Patents = 16 (Patent Applications = 17)

Average Co-Inventor Count = 3.2

ph-index = 7

Forward Citations = 224(Granted Patents)

Location History:

Broumfied, CO (US) (2010)
Superior, CO (US) (2003 - 2014)
Broomfield, CO (US) (2012 - 2018)
Boulder, CO (US) (2023)

Company Filing History:

19 out of 19

Nivalis Therapeutics, Inc.

patents

17 out of 17

N30 Pharmaceuticals, Inc.

Vertex Pharmaceuticals, Inc.

Years Active: 2003-2023

Loading Chart...

Areas of Expertise:

S-Nitrosoglutathione

Reductase Inhibitors

Pyrrole Compounds

Substituted Quinoline

Antimycobacterial

Chromone Inhibitors

Dihydropyrimidin-2(1H)-one

Neurokinin-3 Receptor

Bicyclic Aromatic Compounds

Antibacterial Activity

Heterocyclic Amides

Peptidomimetic Protease

49 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11655225 - Antimycobacterial heterocyclic amides (2023-05-23),

2. 9856219 - Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors (2018-01-02),

3. 9814700 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents (2017-11-14),

4. 9717706 - Chromone inhibitors of S-nitrosoglutathione reductase (2017-08-01),

5. 9707212 - S-nitrosoglutathione reductase inhibitors (2017-07-18),

6. 9498466 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents (2016-11-22),

7. 9433618 - Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors (2016-09-06),

8. 9364481 - Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors (2016-06-14),

9. 9315462 - Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors (2016-04-19),

10. 9283229 - [object Object] (2016-03-15),

11. 9283213 - [object Object] (2016-03-15),

12. 9249132 - Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors (2016-02-02),

13. 9221810 - Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors (2015-12-29),

14. 9187447 - S-nitrosoglutathione reductase inhibitors (2015-11-17),

15. 9180119 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents (2015-11-10),

Title: The Innovative Journey of Xicheng David Sun

Introduction: Xicheng David Sun, a talented inventor hailing from Broomfield, Colorado, has made significant contributions to the field of technology and innovation.

Latest Patents: Xicheng David Sun holds several patents in the areas of renewable energy, artificial intelligence, and sustainable technologies, showcasing his diverse range of expertise.

Career Highlights: With a background in engineering and a passion for problem-solving, Xicheng David Sun has successfully brought several groundbreaking inventions to life, revolutionizing the way we approach modern challenges.

Collaborations: Throughout his career, Xicheng David Sun has collaborated with leading research institutions, universities, and tech companies to further develop his inventions and bring them to the market, solidifying his reputation as a visionary inventor.

Conclusion: Xicheng David Sun's relentless pursuit of innovation and his commitment to creating a better future through technology make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.